Food And Drug Administration
Cipla: Top Sensex Performer Shares of the drug maker rose 3.2 percent to Rs 599 after it received the Establishment Inspection Report from the U.S. Food and Drug Administration for its Indore facility. The company informed about it in a filing to the Bombay Stock Exchange. The report marks
10.29 AM Oct 14th
Cipla pared early gains to end flat. The pharma major on Wednesday said that it has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.
7.03 PM Oct 13th
Cipla was trading higher by 3% to Rs 596 after the drug maker on Wednesday said that it has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.
12.01 PM Oct 13th
the US Food and Drug Administration (USFDA), Lupin Ltd said in a regulatory filing. The Mumbai-based company`s product is a generic version of Allergan`s Namenda XR capsules which are indicated for treatment of moderate to severe dementia of the Alzheimer`s type. According to IMS MAT June 2016 sales data
11.21 PM Sep 29th
It is great news that Aurobindo received approval from US Food and Drug Administration for Levonorgestrel- Ethinyl Estradiol oral and Norethindrone tablets which means this opens up highly lucrative American & Eurpoean this will give a windfall benefits in 2017-18 onwards buy buy and hold
12.29 PM Sep 28th
Wockhardt as a Anand Rathi Sales Note states has received Establishment Inspection Report EIR The report is for its Chikalthana facility for its March 2015 US Food and Drug Administration FDA inspection Upon completion of inspection USFDA provides inspected establishments an inspection
9.57 PM Sep 22nd
food and drug administration (fda) form 483 with some observations in relation to products manufactured prior to execution and implementation of good manufacturing practice (gmp) remediation programme, after the us regulator conducted a 10-days inspection at chikalthana. the recent inspection
4.12 PM Sep 22nd
This man who broke the news to CNBC kept on repeating our sources without mentioning the actual sources. "The US Food and Drug Administration (FDA) has given a clean chit to the Chikalthana plant of Wockhardt , reports CNBC Awaaz quoting sources. Official announcement from the FDA is expected
4.56 PM Sep 18th
(APIs) useful to the company’s business as well as for supply to third party customers,” it added. The US Food and Drug Administration (USFDA) approved facility would help the Bangalore-based company in vertically integrating its oncology related abbreviated new drug application (ANDA) filings
8.11 PM Sep 16th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.